Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IRIDEX Corporation - Common Stock (NQ: IRIX )

1.650 -0.090 (-5.17%)
Streaming Delayed Price Updated: 2:04 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IRIDEX Corporation - Common Stock

< Previous 1 2 3 Next >
Iridex to Report Third Quarter 2022 Financial Results on November 10, 2022
From IRIDEX Corporation
Via GlobeNewswire
Iridex Showcases its Non-Incisional Treatments for Glaucoma, Introduces Sweep Management Software, and Hosts 8 Physician Presentations at AAO 2022
From IRIDEX Corporation
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2022
Upgrades 
Via Benzinga
Recap: Iridex Q2 Earnings
  Iridex (NASDAQ:IRIX) reported its Q2 earnings results on Monday, August 15, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... 
Via Benzinga
Earnings Scheduled For November 11, 2021
Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape... 
Via Benzinga
Earnings Scheduled For May 11, 2021
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is... 
Via Benzinga
Earnings Scheduled For August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
Via Benzinga
Earnings Preview: Iridex
  Iridex (NASDAQ:IRIX) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. Analysts estimate that Iridex will report... 
Via Benzinga
Iridex: Q1 Earnings Insights
Iridex (NASDAQ:IRIX) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Iridex beat estimated earnings by 6.25%,... 
Via Benzinga
50 Biggest Movers From Yesterday
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in... 
Via Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) jumped 57.1% to $1.96 following reports regarding potential future investments from AMC CEO, Adam Aron.... 
Via Benzinga
Iridex: Q4 Earnings Insights
Iridex (NASDAQ:IRIX) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Iridex missed... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Jaguar Health (NASDAQ:JAGX) stock... 
Via Benzinga
The Top 7 Micro-Cap Stocks to Buy Before 2022
Micro-cap stocks offer big growth potential, but not all opportunities are created equal. Each of these earns a Portfolio Grader “A” rating. 
Via InvestorPlace
Clinical Data Published in the Journal of Cardiovascular Electrophysiology Could Be Important for This Stock
BioSig Technologies, Inc. (NASDAQ: BSGM) announced that an article titled "Evaluation of a Novel Cardiac Signal Processing System for Electrophysiology Procedures: The PURE EP 2.0... 
Via Benzinga
How Good Are Iridex's Earnings? | Return On Capital Employed
According to data from Benzinga Pro, during Q2, Iridex's (NASDAQ:IRIX) reported sales totaled $13.43 million. Despite a 38.19% increase in earnings, the company posted a loss of $... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers ADMA Biologics (NASDAQ:ADMA) stock rose 18.79% to $1.77 during Monday's pre-market session. The company's market cap stands at $226.8 million. The company... 
Via Benzinga
Iridex Stock Gains After Posting Highest Sales Since 2007
Iridex Corporation (NASDAQ: IRIX) reported Q2 revenue of $13.4 million, the highest since 2007, +116% Y/Y, beating the consensus of $11.61 million. Cyclo G6 product... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Biolase (NASDAQ:BIOL) stock moved upwards by 42.49% to $0.9 during Friday's pre-market session. The company's market cap stands at $135.3 million. As per... 
Via Benzinga
78 Biggest Movers From Friday
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering. Flora Growth... 
Via Benzinga
Iridex: Q2 Earnings Insights
Shares of Iridex (NASDAQ:IRIX) moved higher by 1.4% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 145.00% over the past... 
Via Benzinga
Return On Capital Employed Overview: Iridex
In Q1, Iridex (NASDAQ:IRIX) posted sales of $11.96 million. Earnings were up 513.67%, but Iridex still reported an overall loss of $1.84 million. Iridex collected $12.30 million... 
Via Benzinga
Recap: Iridex Q1 Earnings
Shares of Iridex (NASDAQ:IRIX) were flat after the company reported Q1 results. Quarterly Results Earnings per share decreased 16.67% year over year to ($0.14), which were in... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Vaxart (NASDAQ:VXRT) shares moved upwards by 53.38% to $9.29 during Tuesday's regular session. Vaxart's stock is trading at a volume of 115.1 million... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Reviva Pharmaceuticals (NASDAQ:RVPH) shares rose 72.91% to $7.47 during Monday's regular session. Reviva Pharmaceuticals's stock is trading at a volume of... 
Via Benzinga
58 Biggest Movers From Yesterday
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its Phase 2 trial... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.